Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kids first?

J Sharfstein1

  • 1Department of Pediatrics, Boston University School of Medicine, 91 East Concord Street, Room 4217, Boston, MA 02118, USA.

International Journal of Health Services : Planning, Administration, Evaluation
|December 29, 2000
PubMed
Summary

Despite a hepatitis B vaccine, 300,000 Americans contract the virus annually. Current vaccination strategies neglect high-risk adults, fueling vaccine hesitancy and hindering prevention efforts for similar diseases like HIV.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Smoking behaviours and attitudes among male restaurant workers in Boston's Chinatown: a pilot study.

Tobacco control·2002
Same author

Is child health at risk while families wait for housing vouchers?

American journal of public health·2001
Same author

Failure to report ethical approval in child health research: review of published papers.

BMJ (Clinical research ed.)·2001
Same author

Child health initiatives and journal narrow-mindedness.

Lancet (London, England)·2000
Same author

Blowing smoke: how cigarette manufacturers argued that nicotine is not addictive.

Tobacco control·1999
Same author

Phenytoin dosage.

Pediatrics·1998

Area of Science:

  • Hepatitis B Virus (HBV) infection
  • Vaccinology
  • Public Health Policy

Background:

  • Hepatitis B remains a significant public health concern in the U.S., with 300,000 new infections annually, nearly 20 years after vaccine licensure.
  • A key challenge in controlling hepatitis B is the low vaccination rate among high-risk adolescents and adults.

Purpose of the Study:

  • To analyze the current strategy for hepatitis B vaccination in the United States.
  • To identify factors contributing to the persistent high incidence of hepatitis B infections.
  • To examine the impact of vaccination policies on public health outcomes and vaccine hesitancy.

Main Methods:

  • The study reviews public health policies and vaccination strategies implemented over the past two decades.
  • It analyzes infection rates in relation to vaccination coverage across different demographic groups.
  • The research also considers the influence of political considerations on public health decision-making.

Main Results:

  • The current U.S. strategy prioritizes vaccinating low-risk infants over high-risk adolescents and adults.
  • This approach has led to a significant number of preventable hepatitis B infections.
  • The suboptimal vaccine utilization may inadvertently contribute to the rise of anti-vaccine sentiments.

Conclusions:

  • The current hepatitis B vaccination strategy is inefficient and politically influenced, failing to protect high-risk populations.
  • A revised approach focusing on vaccinating individuals at higher risk is crucial for controlling hepatitis B.
  • Ineffective hepatitis B vaccine use may negatively impact future efforts to prevent diseases with similar transmission patterns, such as HIV.

Related Experiment Videos